瑞士市场报道
July 19, 2018 / 5:13 AM / in 5 months

BRIEF-Cassiopea: Top Line Positive Proof Of Concept Phase II Results For Cb-06-02 Immune Modulator In Treating Genital Warts

1 分钟阅读

July 19 (Reuters) - CASSIOPEA SPA:

* CASSIOPEA ANNOUNCES TOP LINE POSITIVE PROOF OF CONCEPT PHASE II RESULTS FOR CB-06-02 IMMUNE MODULATOR IN TREATING GENITAL WARTS Source text for Eikon: Further company coverage: (Gdynia Newsroom)

我们的标准：汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below